Clinical Trial Detail

NCT ID NCT03511196
Title Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Leuprolide

Goserelin

Triptorelin

Age Groups: adult senior

No variant requirements are available.